Home  |  Contact

Cellosaurus ME-F2 (CVCL_G313)

[Text version]
Cell line name ME-F2
Synonyms Me-F2
Accession CVCL_G313
Resource Identification Initiative To cite this cell line use: ME-F2 (RRID:CVCL_G313)
Comments Population: Japanese.
Doubling time: 2-3 days (PubMed=8018932).
Omics: Deep quantitative phosphoproteome analysis.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Sequence variations
  • Gene fusion; HGNC; 1539; CBFB + HGNC; 7569; MYH11; Name(s)=CBFB-MYH11 (from parent cell line).
  • Mutation; HGNC; 7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Heterozygous (from parent cell line).
Disease Adult acute myeloid leukemia (NCIt: C9154)
Acute myeloid leukemia (ORDO: Orphanet_519)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_RL95 (ME-2)
Children:
CVCL_G315 (ME-F2/ADM100)CVCL_G316 (ME-F2/ADM200)
Sex of cell Male
Age at sampling 40Y
Category Cancer cell line
Publications

PubMed=8018932; DOI=10.1182/blood.V84.1.84.84
Yanagisawa K., Sato M., Horiuchi T., Hasegawa H., Fujita S.
Difference in response to colony-stimulating factors and involvement of protein kinase C signal transduction system in three subclones from the ME-1 cell line and two sublines.
Blood 84:84-93(1994)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001)

PubMed=21552520; DOI=10.1371/journal.pone.0019169
Gu T.-L., Nardone J., Wang Y., Loriaux M., Villen J., Beausoleil S.A., Tucker M., Kornhauser J.M., Ren J.-M., MacNeill J., Gygi S.P., Druker B.J., Heinrich M.C., Rush J., Polakiewicz R.D.
Survey of activated FLT3 signaling in leukemia.
PLoS ONE 6:E19169-E19169(2011)

Cross-references
Cell line databases/resources cancercelllines; CVCL_G313
Encyclopedic resources Wikidata; Q54904906
Entry history
Entry creation11-Feb-2013
Last entry update05-Oct-2023
Version number17